These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 48137)

  • 41. The Changing Epidemiology of Pediatric Hemoglobinopathy Patients in Northern Alberta, Canada.
    Corriveau-Bourque C; Bruce AA
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):595-9. PubMed ID: 26422283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Echocardiographic abnormalities in thalassaemia major with multiple transfusions.
    Ee B; Tan SH; Yip WC; Tay JS; Chia BL; Wong HB
    J Singapore Paediatr Soc; 1981; 23(1-2):68-70. PubMed ID: 7343780
    [No Abstract]   [Full Text] [Related]  

  • 43. A synopsis of current care of thalassaemia major patients in Hong Kong.
    Au WY; Lee V; Lau CW; Yau J; Chan D; Chan EY; Cheung WW; Ha SY; Kho B; Lee CY; Li RC; Li CK; Lin SY; Ling AS; Mak V; Sun L; Wong KH; Wong R; Yuen HL
    Hong Kong Med J; 2011 Aug; 17(4):261-6. PubMed ID: 21813892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
    Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
    Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia.
    André M; Bergmann P; Ferster A; Toppet M; Fondu P
    Nouv Rev Fr Hematol (1978); 1991; 33(4):299-302. PubMed ID: 1780235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fetal hemoglobin in the follow-up of homozygous beta-thalassemia in blood transfusion treatment].
    Ferrara M; Ponte G; Esposito L
    Pediatria (Napoli); 1980 Dec; 88(4):541-8. PubMed ID: 6170042
    [No Abstract]   [Full Text] [Related]  

  • 47. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
    [No Abstract]   [Full Text] [Related]  

  • 48. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
    Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
    Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of thalassaemia.
    Lancet; 1972 Sep; 2(7775):467-8. PubMed ID: 4115350
    [No Abstract]   [Full Text] [Related]  

  • 50. Transfusion associated hepatitis C in multi-transfused thalassemic children.
    Mishra D; Pensi T
    Indian Pediatr; 2004 Mar; 41(3):287-8. PubMed ID: 15064522
    [No Abstract]   [Full Text] [Related]  

  • 51. Causes of hospital admission in children and adults with transfusion-dependent thalassemia in Sardinia, 2000-2015.
    Origa R; Anni F; Mereu L; Follesa I; Campus S; Dessì C; Foschini ML; Leoni G; Moi P; Morittu M; Orecchia V; Perra M; Zappu A; Podda RA
    Ann Hematol; 2017 Jun; 96(6):1041-1042. PubMed ID: 28280993
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical trial of young red blood cells prepared by apheresis.
    Pisciotto P; Kiraly T; Paradis L; Kakaiya RM; Rink L; Pearson HA
    Ann Clin Lab Sci; 1986; 16(6):473-8. PubMed ID: 3541773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensive transfusion therapy in thalassemia major.
    Beard ME; Necheles TF; Allen DM
    Pediatrics; 1967 Nov; 40(5):911-5. PubMed ID: 6075668
    [No Abstract]   [Full Text] [Related]  

  • 54. A study of blood transfusion services at a district hospital in Malawi.
    Bugge HF; Karlsen NC; Oydna E; Rake MM; Wexels N; Bendabenda J; Roald B; Heier HE; Chisuwo L; Jourdan PM
    Vox Sang; 2013 Jan; 104(1):37-45. PubMed ID: 22765350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Problems related to treatment of beta-thalassaemia major.
    Economidou J
    Paediatrician; 1982; 11(3-4):157-77. PubMed ID: 7043374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of blood transfusion on the immune response of children with thalassaemia.
    Kanakoudi-Tsakalidis F; Spyroglou K; Tzafi R; Cassimos C
    Acta Haematol; 1977; 57(2):65-73. PubMed ID: 402767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Red cell autoantibodies among thalassaemia patients in Hospital Universiti Sains Malaysia.
    Noor Haslina MN; Ariffin N; Illuni Hayati I; Rosline H
    Singapore Med J; 2007 Oct; 48(10):922-5. PubMed ID: 17909677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total management of thalassaemia major.
    Modell B
    Arch Dis Child; 1977 Jun; 52(6):489-500. PubMed ID: 879834
    [No Abstract]   [Full Text] [Related]  

  • 59. Status of oxidant, antioxidantand serum enzymes in thalassaemic children receiving multiple blood transfusions.
    Asif M; Manzoor Z; Farooq MS; Munawar SH; Aziz A; Khan IA
    J Pak Med Assoc; 2015 Aug; 65(8):838-43. PubMed ID: 26228327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A single centre study on birth of children with transfusion-dependent thalassaemia in Malaysia and reasons for ineffective prevention.
    Ngim CF; Ibrahim H; Lai NM; Ng CS
    Prenat Diagn; 2015 Jan; 35(1):51-9. PubMed ID: 25156332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.